EA200901212A1 - 3-имидазолилиндолы, предназначенные для лечения пролиферативных заболеваний - Google Patents
3-имидазолилиндолы, предназначенные для лечения пролиферативных заболеванийInfo
- Publication number
- EA200901212A1 EA200901212A1 EA200901212A EA200901212A EA200901212A1 EA 200901212 A1 EA200901212 A1 EA 200901212A1 EA 200901212 A EA200901212 A EA 200901212A EA 200901212 A EA200901212 A EA 200901212A EA 200901212 A1 EA200901212 A1 EA 200901212A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- proliferative diseases
- imidazolylindoles
- treatment
- intended
- variants
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Abstract
В настоящем изобретении предлагаются соединения, относящиеся к производным 3-гетероциклилиндолила, способным ингибировать взаимодействие между р53, или его вариантами, и MDM2 и/или MDM4, или их вариантами, соответственно, и указанные соединения характеризуются формулой (I), где R, R, R, R, R, Y и Y имеют значения, определенные в описании изобретения. Благодаря их активности, соединения можно использовать для лечения различных заболеваний и нарушений, оппосредованных активностью MDM2 и/или MDM4, или их вариантами, таких как воспалительные заболевания или пролиферативные заболевания или для защиты клеток.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP07105269 | 2007-03-29 | ||
PCT/EP2008/053667 WO2008119741A2 (en) | 2007-03-29 | 2008-03-27 | 3-imidazolyl-indoles for the treatment of proliferative diseases |
Publications (1)
Publication Number | Publication Date |
---|---|
EA200901212A1 true EA200901212A1 (ru) | 2010-04-30 |
Family
ID=38328915
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA200901212A EA200901212A1 (ru) | 2007-03-29 | 2008-03-27 | 3-имидазолилиндолы, предназначенные для лечения пролиферативных заболеваний |
Country Status (27)
Country | Link |
---|---|
US (1) | US8053457B2 (ru) |
EP (1) | EP2142535A2 (ru) |
JP (1) | JP2010522723A (ru) |
KR (1) | KR20090122403A (ru) |
CN (1) | CN101679382A (ru) |
AR (1) | AR065860A1 (ru) |
AU (1) | AU2008234954B9 (ru) |
BR (1) | BRPI0810082A2 (ru) |
CA (1) | CA2682483A1 (ru) |
CL (1) | CL2008000899A1 (ru) |
CR (1) | CR11019A (ru) |
DO (1) | DOP2009000229A (ru) |
EA (1) | EA200901212A1 (ru) |
EC (1) | ECSP099660A (ru) |
GT (1) | GT200900256A (ru) |
IL (1) | IL200862A0 (ru) |
MA (1) | MA31260B1 (ru) |
MX (1) | MX2009010413A (ru) |
NI (1) | NI200900177A (ru) |
PA (1) | PA8774001A1 (ru) |
PE (1) | PE20081897A1 (ru) |
SM (1) | SMP200900085B (ru) |
TN (1) | TN2009000388A1 (ru) |
TW (1) | TW200843746A (ru) |
UY (1) | UY30987A1 (ru) |
WO (1) | WO2008119741A2 (ru) |
ZA (1) | ZA200906210B (ru) |
Families Citing this family (57)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101472584B (zh) * | 2006-04-07 | 2013-04-24 | 詹森药业有限公司 | 用作组胺h4受体调节剂的吲哚类和苯并咪唑类 |
AR070398A1 (es) | 2008-02-22 | 2010-03-31 | Gruenenthal Chemie | Derivados sustituidos de indol |
WO2009158375A1 (en) * | 2008-06-25 | 2009-12-30 | Abbott Laboratories | Aza-cylic indole- 2 -carboxamides and methods of use thereof |
JP6087504B2 (ja) * | 2008-11-07 | 2017-03-01 | マサチューセッツ インスティテュート オブ テクノロジー | アミノアルコールリピドイドおよびその使用 |
PL2380892T3 (pl) | 2009-01-16 | 2014-08-29 | Daiichi Sankyo Co Ltd | Pochodna imidazotiazolowa mająca strukturę pierścienia proliny |
JP2012102017A (ja) * | 2009-03-03 | 2012-05-31 | Astellas Pharma Inc | インドール化合物 |
EP2419408A4 (en) * | 2009-04-16 | 2012-09-05 | Msd Kk | INDOLE SUBSTITUTED DERIVATIVE IN POSITION 3 BY ARYL OR HETEROARYLE |
EP2499145B1 (en) | 2009-11-12 | 2016-01-27 | The Regents Of The University Of Michigan | Spiro-oxindole mdm2 antagonists |
WO2011106650A2 (en) * | 2010-02-27 | 2011-09-01 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Novel p53-mdm2/p53-mdm4 antagonists to treat proliferative disease |
JO2998B1 (ar) * | 2010-06-04 | 2016-09-05 | Amgen Inc | مشتقات بيبيريدينون كمثبطات mdm2 لعلاج السرطان |
WO2012033525A2 (en) | 2010-09-08 | 2012-03-15 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | P53-mdm2 antagonists |
FR2967072B1 (fr) | 2010-11-05 | 2013-03-29 | Univ Dundee | Procede pour ameliorer la production de virus et semences vaccinales influenza |
NZ611866A (en) | 2010-11-12 | 2015-04-24 | Univ Michigan | Spiro-oxindole mdm2 antagonists |
US20120202794A1 (en) * | 2011-01-24 | 2012-08-09 | Pharmasset, Inc. | Compounds |
HUE038714T2 (hu) | 2011-03-10 | 2018-11-28 | Daiichi Sankyo Co Ltd | Dispiropirrolidin származék |
CN102702066A (zh) * | 2011-03-28 | 2012-10-03 | 苏州百灵威超精细材料有限公司 | 一种用于合成抗癌和减肥药物中间体6-氯-5-氟吲哚的制备新方法 |
US9238716B2 (en) | 2011-03-28 | 2016-01-19 | Massachusetts Institute Of Technology | Conjugated lipomers and uses thereof |
US8629141B2 (en) | 2011-05-11 | 2014-01-14 | The Regents Of The University Of Michigan | Spiro-oxindole MDM2 antagonists |
WO2012177927A1 (en) | 2011-06-21 | 2012-12-27 | Mayo Foundation For Medical Education And Research | Transgenic animals capable of being induced to delete senescent cells |
WO2012176123A1 (en) * | 2011-06-22 | 2012-12-27 | Novartis Ag | 3 - imidazolyl- indoles for the treatment of proliferative diseases |
US9408885B2 (en) | 2011-12-01 | 2016-08-09 | Vib Vzw | Combinations of therapeutic agents for treating melanoma |
BR112014014529A2 (pt) | 2011-12-13 | 2019-09-24 | Buck Inst For Res On Aging | métodos para melhorar terapias médicas |
US20150064137A1 (en) | 2012-04-17 | 2015-03-05 | Kythera Biopharmaceuticals, Inc. | Use of engineered viruses to specifically kill senescent cells |
CA2884870C (en) | 2012-08-13 | 2022-03-29 | Massachusetts Institute Of Technology | Amine-containing lipidoids and uses thereof |
US9901081B2 (en) | 2012-08-23 | 2018-02-27 | Buck Institute For Research On Aging | Transgenic mouse for determining the role of senescent cells in cancer |
US9901080B2 (en) | 2012-08-23 | 2018-02-27 | Buck Institute For Research On Aging | Transgenic mouse having a transgene that converts a prodrug into a cytotoxic compound in senescent cells |
TWI586668B (zh) | 2012-09-06 | 2017-06-11 | 第一三共股份有限公司 | 二螺吡咯啶衍生物之結晶 |
BR112015013611A2 (pt) | 2012-12-20 | 2017-11-14 | Merck Sharp & Dohme | composto, e, composição farmacêutica |
WO2014179562A1 (en) | 2013-05-01 | 2014-11-06 | Massachusetts Institute Of Technology | 1,3,5-triazinane-2,4,6-trione derivatives and uses thereof |
US20170216286A1 (en) | 2014-01-28 | 2017-08-03 | Mayo Foundation For Medical Education And Research | Killing senescent cells and treating senescence-associated conditions using a src inhibitor and a flavonoid |
US9993472B2 (en) | 2014-01-28 | 2018-06-12 | Unity Biotechnology, Inc. | Treatment for osteoarthritis in a joint by administering a means for inhibiting MDM2 |
WO2015171591A1 (en) | 2014-05-05 | 2015-11-12 | Board Of Trustees Of The University Of Arkansas | COMPOSITIONS AND METHODS FOR INHIBITING ANTIAPOPTOTIC Bcl-2 PROTEINS AS ANTI-AGING AGENTS |
WO2016004202A1 (en) | 2014-07-02 | 2016-01-07 | Massachusetts Institute Of Technology | Polyamine-fatty acid derived lipidoids and uses thereof |
US10576064B2 (en) | 2014-07-03 | 2020-03-03 | Boehringer Ingelheim International Gmbh | Spiro[3H-indole-3,2′-pyrrolidin]-2(1H)-one compounds and derivatives as MDM2-P53 inhibitors |
US10071087B2 (en) | 2014-07-22 | 2018-09-11 | Bioventures, Llc | Compositions and methods for selectively depleting senescent cells |
JP2018502846A (ja) | 2014-12-26 | 2018-02-01 | ダウ グローバル テクノロジーズ エルエルシー | 有機化合物、及び有機化合物を含む有機層を備える電子デバイス |
TWI711452B (zh) | 2015-02-20 | 2020-12-01 | 日商第一三共股份有限公司 | 癌症的倂用治療法 |
CA2982435C (en) | 2015-04-13 | 2020-05-26 | Daiichi Sankyo Company, Limited | Treatment method by combined use of mdm2 inhibitor and btk inhibitor |
CN114917361A (zh) * | 2015-06-22 | 2022-08-19 | 拜耳医药股份有限公司 | 具有酶可裂解基团的抗体药物缀合物(adc)和抗体前药缀合物(apdc) |
JOP20160198B1 (ar) * | 2015-09-16 | 2022-03-14 | Janssen Pharmaceuticals Inc | مشتقات اندول مستبدلة احاديا او ثنائيا بصفتها مانعات للتكاثر الفيروسي لحمى الفنك |
CN113214270A (zh) | 2015-10-09 | 2021-08-06 | 勃林格殷格翰国际有限公司 | 作为mdm2-p53抑制剂的化合物及其衍生物 |
EP3440082A1 (en) | 2016-04-06 | 2019-02-13 | The Regents of The University of Michigan | Monofunctional intermediates for ligand-dependent target protein degradation |
CA3020275A1 (en) | 2016-04-06 | 2017-10-12 | The Regents Of The University Of Michigan | Mdm2 protein degraders |
KR102447884B1 (ko) | 2016-04-21 | 2022-09-27 | 바이오벤처스, 엘엘씨 | 항-세포자멸적 bcl-2 계열 단백질의 열화를 유도하는 화합물 및 이의 용도 |
CN105906610B (zh) * | 2016-05-24 | 2018-10-23 | 绍兴文理学院 | 一种3-(4-苯基-1h-咪唑-5-基)-1h-吲哚衍生物及其制备方法和应用 |
EP3272745B1 (en) * | 2016-07-21 | 2019-06-26 | Instytut Farmakologii Polskiej Akademii Nauk | Imidazolyl-substituted indole derivatives binding 5-ht7 serotonin receptor and pharmaceutical compositions thereof |
WO2018074387A1 (ja) | 2016-10-17 | 2018-04-26 | 第一三共株式会社 | Mdm2阻害剤とdnaメチルトランスフェラーゼ阻害剤との併用治療法 |
WO2018096159A1 (en) | 2016-11-28 | 2018-05-31 | F. Hoffmann-La Roche Ag | Oxadiazolones as transient receptor potential channel inhibitors |
EP3558388A1 (de) | 2016-12-21 | 2019-10-30 | Bayer Pharma Aktiengesellschaft | Binder-wirkstoff-konjugate (adcs) mit enzymatisch spaltbaren gruppen |
CN110461838B (zh) | 2017-03-07 | 2022-05-06 | 豪夫迈·罗氏有限公司 | 噁二唑瞬时受体电位通道抑制剂 |
JP2020516604A (ja) | 2017-04-05 | 2020-06-11 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 抗がん併用療法 |
JOP20190245A1 (ar) | 2017-04-20 | 2019-10-15 | Novartis Ag | أنظمة توصيل إطلاق مستدام تتضمن روابط بلا أثر لنقطة الربط |
WO2018218192A1 (en) * | 2017-05-26 | 2018-11-29 | Rutgers, The State University Of New Jersey | Bacterial efflux pump inhibitors |
US10710994B2 (en) | 2018-03-19 | 2020-07-14 | Genentech, Inc. | Oxadiazole transient receptor potential channel inhibitors |
AR116566A1 (es) | 2018-10-03 | 2021-05-19 | Novartis Ag | Administración sostenida de polipéptidos similares a la angiopoyetina 3 |
UY39579A (es) * | 2020-12-22 | 2022-07-29 | Novartis Ag | COMPUESTOS Y COMPOSICIÓN PARA EL TRATAMIENTO DE CONDICIONES ASOCIADAS CON cGAS |
WO2022204235A1 (en) * | 2021-03-23 | 2022-09-29 | Nido Biosciences, Inc. | Bicyclic compounds as androgen receptor modulators |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19948417A1 (de) * | 1999-10-07 | 2001-04-19 | Morphochem Ag | Imidazol-Derivate und ihre Verwendung als Arzneimittel |
JP2002114780A (ja) * | 2000-10-11 | 2002-04-16 | Taisho Pharmaceut Co Ltd | 4−(3−インドリル)イミダゾール誘導体 |
CN102627649B (zh) | 2005-02-22 | 2015-03-25 | 密执安州立大学董事会 | Mdm2的小分子抑制剂以及其应用 |
US7576082B2 (en) | 2005-06-24 | 2009-08-18 | Hoffman-La Roche Inc. | Oxindole derivatives |
-
2008
- 2008-03-27 MX MX2009010413A patent/MX2009010413A/es not_active Application Discontinuation
- 2008-03-27 EA EA200901212A patent/EA200901212A1/ru unknown
- 2008-03-27 WO PCT/EP2008/053667 patent/WO2008119741A2/en active Application Filing
- 2008-03-27 KR KR1020097022526A patent/KR20090122403A/ko not_active Application Discontinuation
- 2008-03-27 AU AU2008234954A patent/AU2008234954B9/en not_active Ceased
- 2008-03-27 CN CN200880017611A patent/CN101679382A/zh active Pending
- 2008-03-27 JP JP2010500280A patent/JP2010522723A/ja active Pending
- 2008-03-27 AR ARP080101262A patent/AR065860A1/es unknown
- 2008-03-27 EP EP08735532A patent/EP2142535A2/en not_active Withdrawn
- 2008-03-27 US US12/593,721 patent/US8053457B2/en not_active Expired - Fee Related
- 2008-03-27 PE PE2008000554A patent/PE20081897A1/es not_active Application Discontinuation
- 2008-03-27 CA CA002682483A patent/CA2682483A1/en not_active Abandoned
- 2008-03-27 BR BRPI0810082-9A2A patent/BRPI0810082A2/pt not_active IP Right Cessation
- 2008-03-28 UY UY30987A patent/UY30987A1/es not_active Application Discontinuation
- 2008-03-28 TW TW097111568A patent/TW200843746A/zh unknown
- 2008-03-28 PA PA20088774001A patent/PA8774001A1/es unknown
- 2008-03-28 CL CL2008000899A patent/CL2008000899A1/es unknown
-
2009
- 2009-09-08 ZA ZA200906210A patent/ZA200906210B/xx unknown
- 2009-09-09 CR CR11019A patent/CR11019A/es unknown
- 2009-09-10 IL IL200862A patent/IL200862A0/en unknown
- 2009-09-24 MA MA32230A patent/MA31260B1/fr unknown
- 2009-09-24 TN TNP2009000388A patent/TN2009000388A1/fr unknown
- 2009-09-28 DO DO2009000229A patent/DOP2009000229A/es unknown
- 2009-09-28 NI NI200900177A patent/NI200900177A/es unknown
- 2009-09-28 GT GT200900256A patent/GT200900256A/es unknown
- 2009-09-29 EC EC2009009660A patent/ECSP099660A/es unknown
- 2009-10-28 SM SM200900085T patent/SMP200900085B/it unknown
Also Published As
Publication number | Publication date |
---|---|
TW200843746A (en) | 2008-11-16 |
WO2008119741A2 (en) | 2008-10-09 |
ZA200906210B (en) | 2010-05-26 |
NI200900177A (es) | 2010-09-09 |
ECSP099660A (es) | 2009-10-30 |
AU2008234954B2 (en) | 2011-10-27 |
IL200862A0 (en) | 2010-05-17 |
US20100125064A1 (en) | 2010-05-20 |
AR065860A1 (es) | 2009-07-08 |
MA31260B1 (fr) | 2010-03-01 |
PE20081897A1 (es) | 2009-02-09 |
GT200900256A (es) | 2010-03-15 |
SMP200900085B (it) | 2010-11-12 |
MX2009010413A (es) | 2009-10-20 |
AU2008234954A1 (en) | 2008-10-09 |
PA8774001A1 (es) | 2008-11-19 |
EP2142535A2 (en) | 2010-01-13 |
KR20090122403A (ko) | 2009-11-27 |
CA2682483A1 (en) | 2008-10-09 |
JP2010522723A (ja) | 2010-07-08 |
CN101679382A (zh) | 2010-03-24 |
WO2008119741A3 (en) | 2008-12-04 |
US8053457B2 (en) | 2011-11-08 |
DOP2009000229A (es) | 2009-10-31 |
CL2008000899A1 (es) | 2009-02-20 |
TN2009000388A1 (en) | 2010-12-31 |
UY30987A1 (es) | 2008-10-31 |
CR11019A (es) | 2009-10-20 |
BRPI0810082A2 (pt) | 2014-10-21 |
SMAP200900085A (it) | 2010-01-19 |
AU2008234954B9 (en) | 2012-02-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA200901212A1 (ru) | 3-имидазолилиндолы, предназначенные для лечения пролиферативных заболеваний | |
EA201500769A1 (ru) | Ингибиторы е1 активирующих ферментов | |
EA201071089A1 (ru) | Производные хиназолина как модуляторы raf-киназы и способы их применения | |
EA201001331A1 (ru) | ГЕТЕРОЦИКЛИЧЕСКИЕ СОЕДИНЕНИЯ И СОДЕРЖАЩИЕ ИХ КОМПОЗИЦИИ В КАЧЕСТВЕ ИНГИБИТОРОВ КИНАЗ c-kit И PDGFR | |
EA200900285A1 (ru) | Гетероарильные соединения, применяемые в качестве ингибиторов e1 активирующих ферментов | |
EA201291356A1 (ru) | Пиперидиноновые производные как ингибиторы mdm2 для лечения рака | |
EA201200323A1 (ru) | Соединения и композиции, как ингибиторы протеинкиназы | |
EA201170531A1 (ru) | Соединения на основе пиридина и пиримидина в качестве ингибиторов сигнального пути wnt для лечения рака | |
EA201300684A1 (ru) | Производные 6-амино-2-фениламино-1н-бензимидазол-5-карбоксамида и их применение в качестве ингибиторов микросомной простагландин-е2-синтазы-1 | |
EA200901157A1 (ru) | Конденсированные кольцевые гетероциклические модуляторы киназы | |
EA201071045A1 (ru) | Соединения оксадиазоантрацена для лечения диабета | |
EA201170349A1 (ru) | Модуляторы mif | |
EA201201665A1 (ru) | Новые соединения | |
EA200901032A1 (ru) | Соединения и композиции в качестве модуляторов активности gpr119 | |
EA201391786A1 (ru) | Галоген-алкил-1,3-оксазины в качестве ингибиторов bace1 и/или bace2 | |
EA201100564A1 (ru) | Антипролиферативные соединения | |
EA201170963A1 (ru) | Ингибиторы поли(адф-рибозо)полимеразы (parp) | |
EA201071320A1 (ru) | Активаторы глюкокиназы | |
EA201500394A1 (ru) | Ингибиторы деметилаз гистонов | |
EA201170052A1 (ru) | Производные тиофена или тиазола и их применение как ингибиторов pi3k | |
EA201001329A1 (ru) | Соединения и композиции в качестве модуляторов активности gpr119 | |
EA201270215A1 (ru) | Apaf-1 ингибиторные соединения | |
EA201291073A1 (ru) | Производные транилципромина в качестве ингибиторов гистон деметилаз lsd1 и/или lsd2 | |
EA201691461A1 (ru) | Определенные триазолопиридины и триазолопиразины, их композиции и способы их применения | |
DK2250172T3 (da) | Pyrrolopyrazinkinaseinhibitorer |